Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-042198
Filing Date
2017-06-28
Accepted
2017-06-28 20:47:41
Documents
2
Period of Report
2017-06-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3839
2 POA DOCUMENT poa.txt EX-24.3_733555 3518
  Complete submission text file 0001209191-17-042198.txt   8754
Mailing Address 2530 MERIDIAN PARKWAY SUITE 300 DURHAM NC 27713
Business Address 2530 MERIDIAN PARKWAY SUITE 300 DURHAM NC 27713 919-806-4487
Dova Pharmaceuticals, Inc. (Issuer) CIK: 0001685071 (see all company filings)

IRS No.: 813858961 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DOVA PHARMACEUTICALS, INC. 240 LEIGH FARM ROAD, SUITE 245 DURHAM NC 27707
Business Address
Sapir Alex (Reporting) CIK: 0001709415 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38135 | Film No.: 17936593